Literature DB >> 12695516

YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression.

Karsten Jurchott1, Stephan Bergmann, Ulrike Stein, Wolfgang Walther, Martin Janz, Isabella Manni, Giulia Piaggio, Ellen Fietze, Manfred Dietel, Hans-Dieter Royer.   

Abstract

Expression of the Y-box protein YB-1 is increased in proliferating normal and cancer cells, but its role in cell proliferation and cell cycle progression is unclear. We have identified a cell cycle-dependent relocalization of YB-1 from the cytoplasm to the nucleus at the G1/S phase transition and demonstrate that both the charged zipper and the cold shock domain are involved in regulating this process. Using cell lines that constitutively overexpress YB-1, we show that nuclear accumulation of YB-1 is associated with increased cyclin A and cyclin B1 mRNA and protein expression. We provide evidence that deregulated YB-1 expression is linked to adhesion-independent cell proliferation through the induction of cyclin A. Thus, we have identified YB-1 as a cell cycle stage-specific transcription factor important for cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12695516     DOI: 10.1074/jbc.M212966200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  82 in total

1.  Akt-mediated YB-1 phosphorylation activates translation of silent mRNA species.

Authors:  Valentina Evdokimova; Peter Ruzanov; Michael S Anglesio; Alexey V Sorokin; Lev P Ovchinnikov; Jonathan Buckley; Timothy J Triche; Nahum Sonenberg; Poul H B Sorensen
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

2.  A novel recombinant papillomavirus genome enabling in vivo RNA interference reveals that YB-1, which interacts with the viral regulatory protein E2, is required for CRPV-induced tumor formation in vivo.

Authors:  Natalie Leiprecht; Ekaterina Notz; Johanna Schuetz; Juliane Haedicke; Frank Stubenrauch; Thomas Iftner
Journal:  Am J Cancer Res       Date:  2014-05-26       Impact factor: 6.166

3.  Unraveling regulation and new components of human P-bodies through a protein interaction framework and experimental validation.

Authors:  Dinghai Zheng; Chyi-Ying A Chen; Ann-Bin Shyu
Journal:  RNA       Date:  2011-07-12       Impact factor: 4.942

4.  Proteomic and genomic analysis of PITX2 interacting and regulating networks.

Authors:  Yue Huang; Kan Huang; Goran Boskovic; Yulia Dementieva; James Denvir; Donald A Primerano; Guo-Zhang Zhu
Journal:  FEBS Lett       Date:  2009-01-25       Impact factor: 4.124

5.  Inhibition of protein synthesis by Y box-binding protein 1 blocks oncogenic cell transformation.

Authors:  Andreas G Bader; Peter K Vogt
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

6.  The N-terminal domain of y-box binding protein-1 induces cell cycle arrest in g2/m phase by binding to cyclin d1.

Authors:  Payal Khandelwal; Mythili K Padala; John Cox; Ramareddy V Guntaka
Journal:  Int J Cell Biol       Date:  2010-04-14

7.  Identification of Y-box binding protein 1 as a core regulator of MEK/ERK pathway-dependent gene signatures in colorectal cancer cells.

Authors:  Karsten Jürchott; Ralf-Jürgen Kuban; Till Krech; Nils Blüthgen; Ulrike Stein; Wolfgang Walther; Christian Friese; Szymon M Kiełbasa; Ute Ungethüm; Per Lund; Thomas Knösel; Wolfgang Kemmner; Markus Morkel; Johannes Fritzmann; Peter M Schlag; Walter Birchmeier; Tammo Krueger; Silke Sperling; Christine Sers; Hans-Dieter Royer; Hanspeter Herzel; Reinhold Schäfer
Journal:  PLoS Genet       Date:  2010-12-02       Impact factor: 5.917

Review 8.  Targeting the Y/CCAAT box in cancer: YB-1 (YBX1) or NF-Y?

Authors:  D Dolfini; R Mantovani
Journal:  Cell Death Differ       Date:  2013-03-01       Impact factor: 15.828

9.  Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes.

Authors:  Golareh Habibi; Samuel Leung; Jennifer H Law; Karen Gelmon; Hamid Masoudi; Dmitry Turbin; Michael Pollak; Torsten O Nielsen; David Huntsman; Sandra E Dunn
Journal:  Breast Cancer Res       Date:  2008-10-16       Impact factor: 6.466

10.  Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer.

Authors:  Edgar Dahl; Abdelaziz En-Nia; Frank Wiesmann; Renate Krings; Sonja Djudjaj; Elisabeth Breuer; Thomas Fuchs; Peter J Wild; Arndt Hartmann; Sandra E Dunn; Peter R Mertens
Journal:  BMC Cancer       Date:  2009-11-24       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.